Condition
Recurrent Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Hodgkin Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining Nivolumab and ASTX727 for B-Cell Lymphoma Treatment | Phase 1 | Birmingham, Alabama and 8 other locations | Recruiting | Mar 9, 2022 |
| Treatment for recurrent or refractory Hodgkin lymphoma using a combination of targeted therapy and chemotherapy | Phase 2 | Duarte, California | Recruiting | May 4, 2021 |
| Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions | Phase 2 | Mankato, Minnesota and 3 other locations | Recruiting | Feb 1, 2018 |
| Personalized NK cell therapy after umbilical cord blood transplant for leukemia | Phase 2 | Houston, Texas | Recruiting | Apr 5, 2016 |
All recruiting trials (4)
-
Combining Nivolumab and ASTX727 for B-Cell Lymphoma Treatment
This study is testing a new combination of two treatments, nivolumab and ASTX727, to see if it can help people with relapsed or hard-to-treat B-cell lymphoma feel better and live longer.
-
Treatment for recurrent or refractory Hodgkin lymphoma using a combination of targeted therapy and chemotherapy
This study is testing a new combination of targeted therapy and chemotherapy to see if it can help people with recurring or stubborn Hodgkin lymphoma before they undergo a stem cell transplant.
-
Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions
This study is testing if adding vitamin C to standard chemotherapy can help people with relapsed or hard-to-treat lymphomas and related blood conditions feel better.
-
Personalized NK cell therapy after umbilical cord blood transplant for leukemia
This study is testing if a special treatment using personalized immune cells from umbilical cord blood can help people with leukemia feel better after their transplant.
Related topics
Quick answers
How many Recurrent Hodgkin Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.